Alto Neuroscience
ANRO
ANRO
75 hedge funds and large institutions have $265M invested in Alto Neuroscience in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
29% more funds holding
Funds holding: 58 → 75 (+17)
15.89% more ownership
Funds ownership: 69.2% → 85.09% (+16%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
75
Holding in Top 10
2
Calls
$10.5M
Puts
$7.05M
Top Buyers
| 1 | +$10M | |
| 2 | +$8.29M | |
| 3 | +$7.86M | |
| 4 |
Jennison Associates
New York
|
+$4.24M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$3.73M |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$3.34M | |
| 3 | -$3.02M | |
| 4 |
VM
Valor Management
Chicago,
Illinois
|
-$1.68M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.07M |